Surgery versus radiosurgery in the treatment of brain metastasis.

PubWeight™: 3.75‹?› | Rank: Top 1%

🔗 View Article (PMID 8622147)

Published in J Neurosurg on May 01, 1996

Authors

A K Bindal1, R K Bindal, K R Hess, A Shiu, S J Hassenbusch, W M Shi, R Sawaya

Author Affiliations

1: Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston, USA.

Articles citing this

The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol (2009) 1.96

The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol (2009) 1.70

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiat Oncol (2014) 1.24

Treatment of Brain Metastases. J Clin Oncol (2015) 1.03

Gamma knife radiosurgery for brainstem metastasis. J Korean Neurosurg Soc (2011) 1.01

Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases. Curr Oncol (2013) 0.89

Surgery in 2013 and beyond. J Thorac Dis (2013) 0.88

Clinical management of brain metastasis. J Neurol (1998) 0.87

Neurosurgical management of metastases in the central nervous system. Nat Rev Clin Oncol (2011) 0.87

Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline. Clin Transl Oncol (2013) 0.87

The role of surgical resection in patients with brain metastases. Ecancermedicalscience (2013) 0.86

Brain metastases research 1990-2010: pattern of citation and systematic review of highly cited articles. ScientificWorldJournal (2012) 0.85

Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain. Proc Natl Acad Sci U S A (2014) 0.84

Patients with single brain metastasis from non-small cell lung cancer equally benefit from stereotactic radiosurgery and surgery: a systematic review. Med Sci Monit (2015) 0.84

Single brain metastases from melanoma: remarks on a series of 84 patients. Neurosurg Rev (2011) 0.84

Linac radiosurgery as a tool in neurosurgery. Neurosurg Rev (2005) 0.84

Surgical brain metastases: management and outcome related to prognostic indexes: a critical review of a ten-year series. ISRN Surg (2011) 0.83

The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors. Int J Surg Oncol (2011) 0.82

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival. Radiat Oncol (2013) 0.82

miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α. Oncogene (2015) 0.81

Surgery for brain metastases. Surg Neurol Int (2013) 0.79

Radiosurgery in the treatment of brain metastases: critical review regarding complications. Neurosurg Rev (2007) 0.78

The shifting landscape of metastatic breast cancer to the CNS. Neurosurg Rev (2012) 0.78

Surgical treatment of cerebellar metastases. Surg Neurol Int (2011) 0.78

Surgical resection of brain metastases-impact on neurological outcome. Int J Mol Sci (2013) 0.78

Brain metastasis and treatment. F1000Prime Rep (2014) 0.77

Stereotactic radiosurgery for brain metastases from malignant melanoma. Surg Neurol Int (2015) 0.76

Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? World J Urol (2005) 0.76

Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection. J Oncol (2015) 0.76

Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep (2016) 0.75

Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer. Thorac Cancer (2015) 0.75

Surgery or radiosurgery? J Neurosurg (1997) 0.75

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy. Onco Targets Ther (2016) 0.75

Surgery or radiosurgery. J Neurosurg (1997) 0.75

Surgery or radiosurgery. J Neurosurg (1997) 0.75

Surgery or radiosurgery. J Neurosurg (1997) 0.75

Articles by these authors

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg (2001) 11.58

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol (1999) 8.69

Effect of pregnancy on prognosis for young women with breast cancer. Lancet (1994) 2.92

An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg (2000) 2.50

Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg (1993) 2.49

Deep hypothermia with circulatory arrest. Determinants of stroke and early mortality in 656 patients. J Thorac Cardiovasc Surg (1993) 2.45

Diffuse aneurysmal disease (chronic aortic dissection, Marfan, and mega aorta syndromes) and multiple aneurysm. Treatment by subtotal and total aortic replacement emphasizing the elephant trunk operation. Ann Surg (1990) 2.44

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene (2006) 2.37

Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery (1998) 2.36

Aggressive meningeal tumors: review of a series. J Neurosurg (1995) 2.26

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24

Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg (1986) 2.17

Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol (1996) 2.04

Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene (2007) 1.98

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine (1997) 1.95

Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology (2002) 1.89

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol (1995) 1.89

Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res (1999) 1.88

Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87

Management of intracranial plasmacytoma. J Neurosurg (1995) 1.81

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer (1993) 1.79

Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology (2006) 1.75

Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res (1999) 1.66

Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol (2000) 1.66

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol (1994) 1.64

Cancer among a Michigan cohort exposed to polybrominated biphenyls in 1973. Epidemiology (1998) 1.63

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys (2002) 1.61

Identifying differentially expressed genes in cDNA microarray experiments. J Comput Biol (2001) 1.61

High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol (1994) 1.61

Surgical treatment of multiple brain metastases. J Neurosurg (1993) 1.61

Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg (1998) 1.55

Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol (1994) 1.54

Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol (2001) 1.53

Conventional heart rate variability analysis of ambulatory electrocardiographic recordings fails to predict imminent ventricular fibrillation. J Am Coll Cardiol (1993) 1.51

Surgical treatment of aneurysm and/or dissection of the ascending aorta, transverse aortic arch, and ascending aorta and transverse aortic arch. Factors influencing survival in 717 patients. J Thorac Cardiovasc Surg (1989) 1.49

Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg (1996) 1.44

"Ditzels" on chest CT: survey of members of the Society of Thoracic Radiology. AJR Am J Roentgenol (2001) 1.44

Pallidotomy: a comparison of responders and nonresponders. Neurosurgery (2001) 1.44

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1995) 1.41

Composite valve graft replacement of the proximal aorta: comparison of techniques in 348 patients. Ann Thorac Surg (1992) 1.40

Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery (1997) 1.40

Spinal cord lesion after epidural anesthesia diagnosed by motor evoked potentials. Muscle Nerve (1993) 1.38

Surgery for abdominal metastases of cutaneous melanoma. World J Surg (2001) 1.33

Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res (2000) 1.27

Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res (1996) 1.26

External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys (1997) 1.25

Clinical trial design for microarray predictive marker discovery and assessment. Ann Oncol (2004) 1.24

Acute spontaneous subdural hematoma. Surg Neurol (1984) 1.22

Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. J Neurooncol (2008) 1.22

Aortic dissection and dissecting aortic aneurysms. Ann Surg (1988) 1.20

A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocr Relat Cancer (2005) 1.18

Dandy-Walker syndrome. Clinical analysis of 23 cases. J Neurosurg (1981) 1.17

Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res (1994) 1.16

Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res (1993) 1.16

Volumetric measurement of brain tumors from MR imaging. J Neurooncol (1998) 1.15

A prospective study of respiratory failure after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg (1991) 1.14

Postoperative mutism in neurosurgery. Report of two cases. J Neurosurg (1994) 1.13

Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res (1994) 1.13

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost (2010) 1.12

A prospective randomized study of cerebrospinal fluid drainage to prevent paraplegia after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg (1991) 1.12

Post-caesarean section analgesia: a comparison of epidural butorphanol and morphine. Can J Anaesth (1991) 1.11

Impact of cardiovascular operation on survival in the Marfan patient. Circulation (1989) 1.11

Intraoperative chemical hemostasis in neurosurgery. Neurosurgery (1986) 1.10

Dissection of the aorta and dissecting aortic aneurysms. Improving early and long-term surgical results. Circulation (1990) 1.10

The impact of distal aortic perfusion and somatosensory evoked potential monitoring on prevention of paraplegia after aortic aneurysm operation. J Thorac Cardiovasc Surg (1988) 1.09

Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clin Cancer Res (2000) 1.09

Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res (1993) 1.09

Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction. J Am Coll Cardiol (1993) 1.08

Reconsidering "psychosurgery": issues of informed consent and physician responsibility. J Clin Ethics (1994) 1.07

Determination of brain temperatures for safe circulatory arrest during cardiovascular operation. Ann Thorac Surg (1988) 1.07

Unknown primary tumors metastatic to liver. J Clin Oncol (1998) 1.06

In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene (1997) 1.05

Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis (1995) 1.05

Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. Cancer Res (1999) 1.04

Surgical resection of intrinsic insular tumors: complication avoidance. J Neurosurg (2001) 1.04

Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells. Gene Ther (2008) 1.03

Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. J Gastrointest Surg (2000) 1.02

Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metastasis (1995) 1.01

Intracranial osteolytic malignant meningiomas appearing as extracranial soft-tissue masses. Neurosurgery (1992) 1.01

The prognostic impact of age in patients with triple-negative breast cancer. Breast Cancer Res Treat (2013) 1.01

Reduction of neurologic injury after high-risk thoracoabdominal aortic operation. Ann Thorac Surg (1998) 1.01

Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine. Cell Prolif (1991) 1.00

Ruptured aneurysm of the descending thoracic and thoracoabdominal aorta. Analysis according to size and treatment. Ann Surg (1991) 0.99

Percutaneous transluminal coronary angioplasty in octogenarians. Ann Intern Med (1990) 0.99

Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors. J Neurooncol (2001) 0.98

Variables predictive of outcome in 832 patients undergoing repairs of the descending thoracic aorta. Chest (1993) 0.98

Cerebrospinal fluid drainage and distal aortic perfusion: reducing neurologic complications in repair of thoracoabdominal aortic aneurysm types I and II. J Vasc Surg (1996) 0.97

Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol (2000) 0.96

Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro. Cancer Lett (1996) 0.96

Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions. Int J Cancer (2000) 0.96

Surgical resection of calvarial metastases overlying dural sinuses. Neurosurgery (2001) 0.96

Choroid plexus cyst and chordoid glioma. Report of two cases. Neurosurg Focus (2001) 0.96

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. Ann Oncol (2007) 0.95